Samalin Investment Counsel’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$771K Sell
45,905
-8,147
-15% -$153K 0.27% 104
2025
Q4
$1.03M Sell
54,052
-4,865
-8% -$89.3K 0.37% 67
2025
Q3
$1.02M Buy
58,917
+10,047
+21% +$171K 0.35% 72
2025
Q2
$899K Buy
48,870
+3,907
+9% +$72.6K 0.34% 78
2025
Q1
$928K Buy
44,963
+2,983
+7% +$61K 0.38% 74
2024
Q4
$792K Buy
41,980
+2,743
+7% +$56.7K 0.34% 86
2024
Q3
$866K Buy
39,237
+1,537
+4% +$32.9K 0.38% 70
2024
Q2
$768K Buy
37,700
+960
+3% +$19.1K 0.36% 75
2024
Q1
$738K Buy
36,740
+4,889
+15% +$94K 0.35% 78
2023
Q4
$577K Buy
31,851
+8,957
+39% +$152K 0.29% 107
2023
Q3
$389K Buy
22,894
+7,046
+44% +$131K 0.22% 137
2023
Q2
$302K Buy
+15,848
New +$299K 0.16% 169

Other funds holding THQ

Samalin Investment Counsel's THQ Position: Q1 2026 in Review

Samalin Investment Counsel reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 15% in Q1 2026, selling an estimated $153K and leaving 45,905 shares worth $771K. The position accounts for 0.27% of the portfolio, ranked #104.

Samalin Investment Counsel first reported a position in THQ in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.03M in Q4 2025. 88 funds tracked by Wall St. Rank hold THQ as of Q1 2026.

  • Samalin Investment Counsel held 45,905 shares of abrdn Healthcare Opportunities Fund worth $771K as of Q1 2026.
  • Samalin Investment Counsel sold 8,147 abrdn Healthcare Opportunities Fund shares in Q1 2026, an estimated $153K.
  • abrdn Healthcare Opportunities Fund made up 0.27% of Samalin Investment Counsel's portfolio in Q1 2026, its #104 holding.
  • Samalin Investment Counsel first reported a position in abrdn Healthcare Opportunities Fund in Q2 2023 and has held it in 12 quarters since.
  • Samalin Investment Counsel's abrdn Healthcare Opportunities Fund position peaked at $1.03M in Q4 2025.
  • 88 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q1 2026.

Based on Samalin Investment Counsel's 13F filing for Q1 2026, filed 23 Apr 2026.